Laleh Kamalian, Oisin Douglas, Carol E Jolly, Jan Snoeys, Damir Simic, Mario Monshouwer, Dominic P Williams, B Kevin Park, Amy E Chadwick
Using galactose instead of glucose in the culture medium of hepatoma cell lines, such as HepG2 cells, has been utilized for a decade to unmask the mitochondrial liability of chemical compounds. A modified glucose-galactose assay on HepG2 cells, reducing the experimental period for screening of mitochondrial toxicity to 2 to 4 hr, has been previously reported. HepaRG cells are one of the few cell lines that retain some of the important characteristics of human hepatocytes, offering advantages of working with a cell line, therefore, are considered an alternative for HepG2 cells in drug toxicity screening...
June 2019: Current Protocols in Toxicology